|Articles|July 1, 2015
Addressing Pharma Industry Issues
Richard Johnson, President and CEO of the Parenteral Drug Association (PDA) speaks with Biopharm International.
Advertisement
Richard Johnson, President and CEO of the Parenteral Drug Association (PDA) spoke with BioPharm International about drug shortages, manufacturing challenges, and industry issues.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Neurimmune and AstraZeneca Expand Efforts to Accelerate Fibril-Depleting Therapies
2
New Draft Guidance Highlights FDA Push Toward Human-Relevant Safety Models
3
New Lymphoma Indication for CAR T-Cell Therapy Shapes Pipeline
4
Implementing Automation and Flexible Design for Allogeneic Manufacturing
5
